专题:Systemic Sclerosis and Related Diseases

This cluster of papers focuses on the pathogenesis, clinical manifestations, and treatment of systemic sclerosis, with an emphasis on fibrosis, autoantibodies, pulmonary involvement, and the role of TGF-ß signaling. It also explores genetic markers, endothelial dysfunction, and various treatment approaches including immunosuppressive therapy for this complex autoimmune disease.
最新文献
Antiphospholipid antibodies and cardiovascular thrombosis

article Full Text OpenAlex

‘Water Target Sign’ on CT Scan in Systemic Lupus Erythematosus: Correspondence

article Full Text OpenAlex

Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvement

article Full Text OpenAlex

Adipocyte-Specific Deletion of Sine Oculis Homeobox Homolog 1 Inhibits Lipolysis and Reduces Skin Fibrosis

article Full Text OpenAlex

A potent inhibitor of PAI-1, MDI-2517, mitigates disease severity in a preclinical systemic sclerosis model

article Full Text OpenAlex

Frailty and functional outcomes in patients with progressive fibrosing interstitial lung diseases receiving antifibrotic therapy: a real-life observational study

article Full Text OpenAlex

Pulmonary alveolar proteinosis developing during tofacitinib treatment for anti–MDA5 antibody–positive dermatomyositis–associated interstitial lung disease: a case report and review of the literature

article Full Text OpenAlex

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder

article Full Text OpenAlex

Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis

article Full Text OpenAlex

Exploring the Vasculitis‐Tumors Link: Epidemiological Patterns, Mechanistic Insights, and Clinical Implications

article Full Text OpenAlex

近5年高被引文献
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

article Full Text OpenAlex 2406 FWCI345.6236

Systemic sclerosis

review Full Text OpenAlex 486 FWCI65.8802

Interstitial lung diseases

review Full Text OpenAlex 463 FWCI64.4435

Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial

article Full Text OpenAlex 247 FWCI35.3611

Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019

review Full Text OpenAlex 212 FWCI54.1057

Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells

letter Full Text OpenAlex 189 FWCI48.8496

Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis

review Full Text OpenAlex 180 FWCI47.2111

State-of-the-art evidence in the treatment of systemic sclerosis

review Full Text OpenAlex 176 FWCI45.6448

EULAR recommendations for the treatment of systemic sclerosis: 2023 update

article Full Text OpenAlex 171 FWCI74.6934

Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria

review Full Text OpenAlex 161 FWCI246.0611